{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T03:35:21Z","timestamp":1789097721753,"version":"build-2803163510"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,11,20]],"date-time":"2019-11-20T00:00:00Z","timestamp":1574208000000},"content-version":"am","delay-in-days":354,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100006492","name":"Division of Intramural Research, National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006492","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jpeds.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pediatrics"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1016\/j.jpeds.2018.08.010","type":"journal-article","created":{"date-parts":[[2018,11,20]],"date-time":"2018-11-20T05:04:13Z","timestamp":1542690253000},"page":"391-399.e1","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":51,"special_numbering":"C","title":["Long-Term Parathyroid Hormone 1-34 Replacement Therapy in Children with Hypoparathyroidism"],"prefix":"10.1016","volume":"203","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8261-5188","authenticated-orcid":false,"given":"Karen K.","family":"Winer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Kelly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alicia","family":"Johns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Dowdy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James C.","family":"Reynolds","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul S.","family":"Albert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr","given":"Gordon B.","family":"Cutler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpeds.2018.08.010_bib0010","doi-asserted-by":"crossref","first-page":"3307","DOI":"10.1210\/jc.2008-1216","article-title":"Hypoparathyroidism: is it time for replacement therapy?","volume":"93","author":"Horowitz","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jpeds.2018.08.010_bib0015","doi-asserted-by":"crossref","first-page":"G1","DOI":"10.1530\/EJE-15-0628","article-title":"European Society of Endocrinology Clinical Guideline: treatment of chronic hypoparathyroidism in adults","volume":"173","author":"Bollerslev","year":"2015","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.jpeds.2018.08.010_bib0020","first-page":"47","article-title":"Perspectives on the search for a true physiologic replacement therapy for hypoparathyroidism","volume":"12","author":"Winer","year":"2016","journal-title":"Eur Endocrinol"},{"key":"10.1016\/j.jpeds.2018.08.010_bib0025","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1203\/00006450-199710000-00004","article-title":"A Ca (2+) sensing receptor mutation causes hypoparathyroidism by increasing receptor sensitivity to CA2+ and maximal signal transduction","volume":"42","author":"Mancilla","year":"1997","journal-title":"Pediatr Res"},{"key":"10.1016\/j.jpeds.2018.08.010_bib0030","first-page":"3480","article-title":"A randomized, crossover trial of once-daily versus twice-daily human parathyroid hormone 1-34 in the treatment of hypoparathyroidism","volume":"83","author":"Winer","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jpeds.2018.08.010_bib0035","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1001\/jama.1996.03540080053029","article-title":"Synthetic human parathyroid hormone 1-34 vs calcitriol and calcium in the treatment of hypoparathyroidism: results of a randomized crossover trial","volume":"276","author":"Winer","year":"1996","journal-title":"JAMA"},{"key":"10.1016\/j.jpeds.2018.08.010_bib0040","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1002\/jbmr.1979","article-title":"Cardiovascular and renal complications to postsurgical hypoparathyroidism: a Danish nationwide controlled historic follow-up study","volume":"28","author":"Underbjerg","year":"2013","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.jpeds.2018.08.010_bib0045","first-page":"4507","article-title":"Hypoparathyroidism","volume":"97","author":"Mannstadt","year":"2017","journal-title":"Nat Dis Primers"},{"key":"10.1016\/j.jpeds.2018.08.010_bib0050","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1111\/j.1365-2796.2009.02090.x","article-title":"Clinical manifestations and management of patients with autoimmune polyendocrine syndrome type I","volume":"265","author":"Husebye","year":"2009","journal-title":"J Intern Med"},{"key":"10.1016\/j.jpeds.2018.08.010_bib0055","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.88782","article-title":"Redefined clinical features and diagnostic criteria in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy","author":"Ferre","year":"2016","journal-title":"JCI Insight"},{"key":"10.1016\/j.jpeds.2018.08.010_bib0060","doi-asserted-by":"crossref","first-page":"5313","DOI":"10.1210\/jcem.86.11.8016","article-title":"Activating mutations of the calcium-sensing receptor: management of hypocalcemia","volume":"86","author":"Lienhardt","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jpeds.2018.08.010_bib0065","doi-asserted-by":"crossref","first-page":"3389","DOI":"10.1210\/jc.2007-2552","article-title":"Effects of once versus twice-daily parathyroid hormone 1-34 therapy in children with hypoparathyroidism","volume":"93","author":"Winer","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jpeds.2018.08.010_bib0070","doi-asserted-by":"crossref","first-page":"2680","DOI":"10.1210\/jc.2009-2464","article-title":"Long-term treatment of 12 children with chronic hypoparathyroidism: a randomized trial comparing synthetic human parathyroid hormone 1-34 versus calcitriol and calcium","volume":"95","author":"Winer","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jpeds.2018.08.010_bib0075","first-page":"391","article-title":"Synthetic human parathyroid hormone 1-34 replacement therapy: a randomized crossover trial comparing pump versus injections in the treatment of chronic hypoparathyroidism","volume":"97","author":"Winer","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jpeds.2018.08.010_bib0080","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.jpeds.2014.04.060","article-title":"Effects of pump versus twice-daily injection delivery of synthetic parathyroid hormone 1-34 in children with severe congenital hypoparathyroidism","volume":"165","author":"Winer","year":"2014","journal-title":"J Pediatr"},{"key":"10.1016\/j.jpeds.2018.08.010_bib0085","doi-asserted-by":"crossref","first-page":"4214","DOI":"10.1210\/jc.2002-021736","article-title":"Long-term treatment of hypoparathyroidism: a randomized controlled study comparing parathyroid hormone (1-34) versus calcitriol and calcium","volume":"88","author":"Winer","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jpeds.2018.08.010_bib0090","doi-asserted-by":"crossref","first-page":"2742","DOI":"10.1210\/jc.2015-4135","article-title":"Therapy of hypoparathyroidism with PTH (1-84): a prospective six-year investigation of efficacy and safety","volume":"101","author":"Rubin","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jpeds.2018.08.010_bib0095","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.2214\/ajr.146.6.1253","article-title":"Renal calcium deposition in children: sonographic demonstration of the Anderson-Carr progression","volume":"146","author":"Patriquin","year":"1986","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.jpeds.2018.08.010_bib0100","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1210\/jc.2012-2747","article-title":"Ultrasound is superior to computed tomography for assessment of medullary nephrocalcinosis in hypoparathyroidism","volume":"98","author":"Boyce","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jpeds.2018.08.010_bib0105","first-page":"1","article-title":"2000 CDC Growth Charts for the United States: methods and development","volume":"246","author":"Kuczmarski","year":"2002","journal-title":"Vital Health Stat 11"},{"key":"10.1016\/j.jpeds.2018.08.010_bib0110","doi-asserted-by":"crossref","first-page":"3160","DOI":"10.1210\/jc.2011-1111","article-title":"Revised reference curves for bone mineral content and areal bone mineral density according to age and sex for black and non-black children: results of the bone mineral density in childhood study","volume":"96","author":"Zemel","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jpeds.2018.08.010_bib0115","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1210\/jc.2009-2057","article-title":"Height adjustment in assessing dual energy x-ray absorptiometry measurements of bone mass and density in children","volume":"95","author":"Zemel","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jpeds.2018.08.010_bib0120","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.1210\/jc.2013-4455","article-title":"Age-based reference ranges for annual height velocity in US children","volume":"99","author":"Kelly","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jpeds.2018.08.010_bib0125","first-page":"1257","article-title":"Polyglandular autoimmune syndrome type I - a novel AIRE mutation in a North American patient","volume":"27","author":"Huibregtse","year":"2014","journal-title":"J Pediatr Endocrinol Metab"},{"key":"10.1016\/j.jpeds.2018.08.010_bib0130","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S2213-8587(13)70106-2","article-title":"Efficacy and safety of recombinant human parathyroid hormone (1-84) in hypoparathyroidism (REPLACE): a double-blind, placebo-controlled, randomized phase 3 study","volume":"1","author":"Mannstadt","year":"2014","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.jpeds.2018.08.010_bib0135","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1210\/jc.2015-3910","article-title":"Management of hypoparathyroidism","volume":"101","author":"Bilezikian","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jpeds.2018.08.010_bib0140","doi-asserted-by":"crossref","first-page":"3694","DOI":"10.1210\/jc.2014-2267","article-title":"PTH (1-84) is associated with improved quality of life in hypoparathyroidism through 5 years of therapy","volume":"99","author":"Cusano","year":"2014","journal-title":"J Clin Endocrinol Metabol"},{"key":"10.1016\/j.jpeds.2018.08.010_bib0145","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1210\/jcem.84.2.5498","article-title":"Parathyroid hormone deficiency and excess: similar effects on trabecular bone but differing effects on cortical bone","volume":"84","author":"Duan","year":"1999","journal-title":"J Clin Endocrinol Metabol"},{"key":"10.1016\/j.jpeds.2018.08.010_bib0150","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1359\/jbmr.080803","article-title":"Dynamic and structural properties of the skeleton in hypoparathyroidism","volume":"23","author":"Rubin","year":"2008","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.jpeds.2018.08.010_bib0155","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1053\/j.ajkd.2010.02.340","article-title":"KDOQI US commentary on 2009 KDIGO clinical practice guideline for the diagnosis, evaluation and treatment of CKD-Mineral and Bone Disorder (CKD-MBD)","volume":"55","author":"Uhlig","year":"2010","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.jpeds.2018.08.010_bib0160","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1038\/sj.ki.5002412","article-title":"The fallacy of the calcium-phosphorus product","volume":"72","author":"O'Neill","year":"2007","journal-title":"Kidney Int"},{"key":"10.1016\/j.jpeds.2018.08.010_bib0165","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1359\/jbmr.080208","article-title":"Perspective on the interpretation of rat carcinogenicity studies for human PTH 1-34 and human PTH 1-84","volume":"23","author":"Tashjian","year":"2008","journal-title":"J Bone Miner Res"}],"container-title":["The Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002234761831120X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002234761831120X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T08:58:48Z","timestamp":1758358728000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002234761831120X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":32,"alternative-id":["S002234761831120X"],"URL":"https:\/\/doi.org\/10.1016\/j.jpeds.2018.08.010","relation":{},"ISSN":["0022-3476"],"issn-type":[{"value":"0022-3476","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long-Term Parathyroid Hormone 1-34 Replacement Therapy in Children with Hypoparathyroidism","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pediatrics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpeds.2018.08.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}